Search NLS News

Orion Corporation has entered into an agreement with Chinese Jemincare, through which Orion will receive exclusive global development and commercialization rights, excluding the Greater China area (mainland China, Hong Kong, Macau and Taiwan), for a potent and selective NaV 1.8 blocker for the treatment of acute and chronic pain. Orion will also receive ownership to […]

Gedea Biotech has received regulatory approval from the Ethics Committee and the Swedish Medical Products Agency and will start the EpHect clinical study of its lead product, pHyph, a vaginal tablet for topical treatment. The open-labelled study is designed to confirm the safety and efficacy of pHyph in treating adult women with confirmed Vulvo Vaginal […]

The company has announced a new collaboration in the field of precision diagnostics to develop solutions for improved clinical diagnostics of bladder cancer. Bladder cancer is the third classifier model co-operation launched by Qlucore in the area of solid tumours. Cooperate with Lund University Combining Qlucore’s expertise in bioinformatic software and cancer diagnostics from Lund […]

ISD Immunotech has announced the appointment of Gert Bolwig as the company’s Chief Executive Officer. Gert Bolwig will be succeeding Ingelise Sunders who has acted as Executive Chairman. Ms. Saunders will continue as Chairman of the Board. “We are delighted to have Gert join our company,” says Ingelise Saunders, Chairman of the Board. “Gert is […]

Ilya Pharma has announced that the Indian Patent Office (IPO) has issued the Company Patent titled “Methods for Wound Healing”. The patent covers the general use of a plasmid capable of expressing the protein CXCL12 in L. reuteri. The modified bacteria may be used for treatment of both mucosal and cutaneous wounds in humans and […]

The manifesto, launched by the trade association for the research-based pharmaceutical industry in Sweden (Lif), includes nine commitments that covers the entire value chain of medicines, from research and development through manufacturing, to marketing and use. The manifesto has both the individual patient and society as a whole in focus, and it is divided into […]

Evident has unveiled the winners of its third Global Image of the Year Life Science Light Microscopy Award, an annual competition that recognizes the best in life science imaging. The contest launched on Oct. 19, 2021, with a call for users to submit their best life science microscopy images through Jan. 31, 2022. All entries […]

The prosecutors in the Paolo Macchiarini trial asked the court on Monday for at least five years in prison for the surgeon. Macchiarini went on trial April 27 in Sweden charged with aggravated assault, 11 years after he first performed experimental transplants of synthetic windpipes on patients. The trial has centered on three transplants Macchiarini […]

EMA’s human medicines committee (CHMP) has recommended the suspension of the marketing authorizations of several generic medicines tested by Synchron Research Services, a contract research organization (CRO) located in Ahmedabad, India. The recommendation comes after irregularities were found in how the CRO carried out bioequivalence studies, which raised serious concerns about the company’s quality management […]

Calliditas Therapeutics has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the granting of a conditional marketing authorisation for Kinpeygo for the treatment of primary immunoglobulin A (IgA) nephropathy (IgAN) in adults at risk of rapid disease progression with a urine […]